Grey Wolf Animal Health Insider Trading

TSX-V WOLF


1

All Trades

0

Significant

1

Notable

0

Clusters

0

Repeat

Consumer Cyclical

Sector

Personal Services

Industry

$60.0M

Market Cap

1.00 – 1.85

52 Week Range

4K

Avg. Volume


CompanyInsiderTitleTr. DateFi. DateSharesPriceValueBalanceIncreaseSignal
Grey Wolf Animal HealthPalmer, KevinCFO13-Jun-2516-Jun-2521,000$1.05$22,05021,000NewNT

Company Info

Grey Wolf Health Corp. is a Canadian animal health and wellness company operating in two business segments: Animal Health and Pharmacy. The company sells, markets, and distributes pharmaceutical, nutraceutical, and consumable products to veterinary clinics, and also supplies pharmaceuticals for both human and animal health markets. Its animal health product portfolio includes dexmedetomidine hydrochloride oromucosal gel under the SILEO brand, sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names, and prescription drugs under the THYRO-TABS CANINE name. The company also offers a range of wound care products, including medical grade tubes, viscose net dressings, alginate dressings, absorbent foam dressings, superabsorbent dressings, and silicone perforated tapes. Its protective wear line includes pet shirts, boots, head covers, and leg sleeves sold under the medical pet shirt brand. Additional products include disposables such as syringes, needles, and IV catheters, as well as nutraceuticals and equine health products. The company was formerly known as Grey Wolf Animal Health Corp. and adopted its current name in June 2026. It is headquartered in Toronto, Canada.






Don’t miss today’s trades

Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.

Subscribe Now